Authors



Benyam Muluneh, PharmD, CPP

Latest:

Metastatic Breast Cancer Updates

Incremental gains in survival and new targeted agents in the pipeline offer promise.






Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP

Latest:

Cannabidiol Gets Thumbs Up from Federal Agencies

The FDA approved cannabidiol (CBD) last year for the treatment of seizures associated with Lennox-Gastaut and Dravet syndromes in patients aged 2 years and older. As pharmacists, we will likely be called upon as experts in CBD therapeutics.


Yunlu Chen, PharmD Candidate

Latest:

Through Thick and Thin: Using Anticlotting Drugs

Helping patients understand their regimen can boost adherence.



Hélène Parisé, MA

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.



Meghana Aruru, MBA, PhD (Cand)

Latest:

Examining Part D Beneficiaries' Medication Use in the Doughnut Hole

The authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.



Jamie Paek, PharmD

Latest:

Challenges, Opportunities Mark Health Care Landscape in 2022

Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend


Steve Dudley, PharmD, DABAT

Latest:

Poison Control Centers Offer Unique Opportunities for Pharmacists

More than $45 million in health care expenditures is prevented, and that money saved, annually by Arizona’s 2 poison control centers. But what do they do?



Joseph Cremaldi, PhD

Latest:

A Predictive Modeling Primer for Specialty Pharmacy

As the industry focuses more on value-based care, predictive modeling allows pharmacies to shift their services from a one-size-fits-all approach to a personalized, high-touch strategy.


Caitlin Turnbull, PharmD candidate

Latest:

The Implications of Antibiotic Overuse Warrant Attention to Guidelines

Up to half of antibiotics prescribed in the United States may be unnecessary, leading to avoidable adverse events and development of antibiotic resistance and attendant costs.


Sean Swisher, PharmD, RPIC

Latest:

Current Tech Hurdles in Specialty Pharmacy Lead to a Decrease in Effective Care

Lost within the fast-paced specialty pharmacy environment are updates to pharmacy software systems that can accommodate the ever-growing needs of patients.


Saro Arakelians, PharmD

Latest:

Myelofibrosis Treatment Options: A Guide for Pharmacists

Treatment options may include treating the anemia with blood transfusions, androgen therapy, thalidomide, and other medications.



Tony Hagen, OncLive

Latest:

Any Willing Provider Legislation May Squeeze Independent Practice Pharmacies

Independents grapple with increasingly aggressive policies among payers, pharmacy benefit managers, and pharma companies.


David A. Kvancz, MS, RPh, FASHP

Latest:

Predictive Analytics: A Case Study in Machine-Learning and Claims Databases

A state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.


Hannah Fish, PharmD, CPHQ

Latest:

Gaps in Immunization Measurement

In the United States, vaccine-preventable diseases cause tens of thousands of deaths each year.


June M. McKoy, MD, MPH, JD

Latest:

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.


Gale Scott, HCPLive

Latest:

Enterovirus May Have Peaked

Enterovirus-D68 could soon be in the rearview mirror, according to a Hartford, CT, pediatric intensivist who has treated more than 20 children hospitalized with the infection.


Jessica DeMartino, PhD

Latest:

Impact of Risk Evaluation and Mitigation Strategies in Oncology

When used fittingly, REMS can ensure safe use of prescribed drugs. However, applying REMS to oncology and supportive-care drugs must be done carefully.


Meagan Balding, PharmD Candidate

Latest:

SBRT Improves Options for Prostate Cancer

For some patients, stereotactic body radiation therapy may provide an enhanced quality of life, better efficacy, and reduced adverse effects.


Elizabeth Shald, PharmD Candidate

Latest:

What Are Treatment Approaches to Liver Cancer?

How to treat hepatocellular carcinoma is heavily influenced by the burden of disease at diagnosis.


Robert Scholz, RPh, MS, MBA

Latest:

Avoidable Readmissions

In the past year, more than 2200 hospitals have been penalized $280 million for "excessive" readmission rates under the Centers for Medicare & Medicaid Services' Readmissions Reduction Program, and the penalties will become more severe as the maximum penalty rises to 3% by 2014.